glutamine has been researched along with Bowel Diseases, Inflammatory in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ai, K; Huang, W; Liu, G; Wang, J; Xu, K; Zhang, J | 1 |
| Alves da Silva, AC; da Silva Barros, VJ; Dos Santos, AA; Lima, MM; Luz Parente, JM; Matos Neto, EM; Moreira Lima, AÂ; Severo, JS; Tolentino Bento da Silva, M | 1 |
| Kim, H; Kim, MH | 1 |
| Abedi, V; Bassaganya-Riera, J; Hontecillas, R; Leber, A; Tubau-Juni, N; Zoccoli-Rodriguez, V | 1 |
| Abrantes, FA; Andrade, ME; Araújo, RS; Cardoso, VN; de Barros, PA; Fernandes, SO; Generoso, Sde V; Soares, AD | 1 |
| Alvarez, L; Beltrán, CJ; Castro, A; Hermoso, MA; Lahsen, FM; Leal, AD; Quera, R; Torres, T; Venegas, M | 1 |
| Sufit, AJ; Wischmeyer, PE; Xue, H | 1 |
| González-Castillo, S; Guagnozzi, D; Lucendo, AJ; Olveira, A | 1 |
| Crespo, I; Cuevas, MJ; González-Gallego, J; Marroni, N; Prause, C; San-Miguel, B; Tuñón, MJ | 1 |
| Goh, J; O'Morain, CA | 1 |
| Coëffier, M; Déchelotte, P; Ducrotté, P; Marion, R | 1 |
| Bischoff, SC; Borchert, K; Lochs, H; Manns, MP; Ockenga, J; Stüber, E | 1 |
| Gloro, R; Justum, AM; Piquet, MA; Reimund, JM | 1 |
| Belmonte, L; Coëffier, M; Daveau, M; Déchelotte, P; Ducrotté, P; Hecketsweiler, B; Hiron, M; Le Pessot, F; Lemeland, JF; Leplingard, A; Miralles-Barrachina, O | 1 |
| Griffiths, AM; Ling, SC | 1 |
| Jonas, CR; Ziegler, TR | 1 |
8 review(s) available for glutamine and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Effects of glutamine supplementation on inflammatory bowel disease: A systematic review of clinical trials.
Topics: Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Dietary Supplements; Glutamine; Humans; Inflammatory Bowel Diseases | 2021 |
The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases.
Topics: Animals; Glutamine; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Intestines | 2017 |
The role of immunomodulators on intestinal barrier homeostasis in experimental models.
Topics: Animals; Arginine; Bifidobacterium; Citrulline; Disease Models, Animal; Epithelial Cells; Fatty Acids, Omega-3; Glutamine; Homeostasis; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Intestinal Mucosa; Lactobacillus; Linoleic Acids, Conjugated; Permeability; Probiotics; Saccharomyces; Tryptophan | 2015 |
Nutritional treatment in inflammatory bowel disease. An update.
Topics: Adult; Age Factors; Avitaminosis; Child; Dietary Carbohydrates; Enteral Nutrition; Fermentation; Glutamine; Humans; Immunomodulation; Inflammatory Bowel Diseases; Intercellular Signaling Peptides and Proteins; Intestinal Mucosa; Micronutrients; Nutrigenomics; Nutritional Support; Parenteral Nutrition; Permeability; Protein-Energy Malnutrition; Remission Induction | 2012 |
Review article: nutrition and adult inflammatory bowel disease.
Topics: Butyrates; Calcium, Dietary; Colitis, Ulcerative; Crohn Disease; Diet; Enteral Nutrition; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Folic Acid; Glutamine; Humans; Inflammatory Bowel Diseases; Nutritional Physiological Phenomena; Nutritional Status; Parenteral Nutrition; Probiotics; Triglycerides | 2003 |
[Nutritional therapy in inflammatory bowel disease].
Topics: Antioxidants; Enteral Nutrition; Fatty Acids, Omega-3; Glutamine; Humans; Inflammatory Bowel Diseases; Malnutrition; Probiotics; Secondary Prevention; Transforming Growth Factor beta | 2006 |
Nutrition in inflammatory bowel disease.
Topics: Anorexia; Antioxidants; Bone Density; Butyrates; Crohn Disease; Cytokines; Enteral Nutrition; Fatty Acids, Omega-3; Glutamine; Growth Disorders; Humans; Inflammatory Bowel Diseases; Nutrition Disorders; Nutritional Physiological Phenomena; Osteoporosis | 2000 |
Potential role of glutamine administration in inflammatory bowel disease.
Topics: Animals; Disease Models, Animal; Glutamine; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Nutrition Disorders; Oxidative Stress; Short Bowel Syndrome | 1999 |
1 trial(s) available for glutamine and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease.
Topics: Acute Disease; Adult; Dietary Supplements; Dipeptides; Disease Progression; Female; Glutamine; Humans; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Lactulose; Male; Middle Aged; Nitrogen; Nutritional Status; Parenteral Nutrition, Total; Permeability; Sample Size; Time Factors; Xylose | 2005 |
7 other study(ies) available for glutamine and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
The role of neurotransmitters in mediating the relationship between brain alterations and depressive symptoms in patients with inflammatory bowel disease.
Topics: Brain; Depression; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Inflammatory Bowel Diseases; Magnetic Resonance Imaging; Neurotransmitter Agents | 2023 |
NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease.
Topics: Animals; Cells, Cultured; Clostridiales; Colitis; Dextran Sulfate; Dietary Supplements; Disease Models, Animal; Epithelial Cells; Gastrointestinal Microbiome; Glutamine; Humans; Immunity, Innate; Inflammation; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondrial Proteins; Veillonella | 2018 |
IL-23R Arg381Gln polymorphism in Chilean patients with inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Arginine; Chile; Female; Glutamine; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Polymorphism, Genetic; Receptors, Interleukin | 2008 |
Glutamine therapy improves outcome of in vitro and in vivo experimental colitis models.
Topics: Animals; Area Under Curve; Caspase 3; Cell Survival; Colitis; Colon; Cytokines; Dextran Sulfate; Diarrhea; Disease Models, Animal; Dose-Response Relationship, Drug; Epithelial Cells; Glutamine; Heat-Shock Proteins; Hemorrhage; HSP70 Heat-Shock Proteins; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice; NF-kappa B; Nitric Oxide Synthase Type II; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley | 2011 |
Glutamine treatment attenuates endoplasmic reticulum stress and apoptosis in TNBS-induced colitis.
Topics: Animals; Apoptosis; Brefeldin A; Caco-2 Cells; Caspases; Cell Line, Tumor; Cell Survival; Colitis; Endoplasmic Reticulum; Glutamine; Humans; Immunohistochemistry; Inflammatory Bowel Diseases; Male; Oxidative Stress; Phosphorylation; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Transcription Factor CHOP; Trinitrobenzenesulfonic Acid; Tunicamycin | 2012 |
Modulating effect of glutamine on IL-1beta-induced cytokine production by human gut.
Topics: Adult; Cytokines; Duodenum; Female; Glutamine; Humans; Inflammatory Bowel Diseases; Interleukin-1; Interleukin-10; Interleukin-4; Interleukin-6; Interleukin-8; Intestinal Mucosa; Male; Organ Culture Techniques; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2003 |
Effects of glutamine supplementation on gut barrier, glutathione content and acute phase response in malnourished rats during inflammatory shock.
Topics: Acute-Phase Proteins; Acute-Phase Reaction; Animals; Bacterial Translocation; Blood Proteins; Dietary Supplements; Disease Models, Animal; Glutamine; Glutathione; Glycoproteins; Inflammatory Bowel Diseases; Intestinal Mucosa; Irritants; Liver; Male; Malnutrition; Orosomucoid; Rats; Rats, Sprague-Dawley; RNA, Messenger; Turpentine | 2007 |